Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cosequin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Changes to articular cartilage following remote application of radiofrequency energy and with or without Cosequin therapy.
OBJECTIVE To determine the short- and long-term changes in the biomechanical properties and metabolic activity of articular… Expand
Is this relevant?
Review
2009
Review
2009
Low quality of evidence for glucosamine-based nutraceuticals in equine joint disease: review of in vivo studies.
Nutraceuticals are increasingly applied to the management of equine arthritis and joint disease, particularly those based upon… Expand
  • table 1
  • table 2
  • figure 1
  • table 4
  • table 3
Is this relevant?
2009
2009
A Flavonoid Mixture, Dual Inhibitor of Cyclooxygenase and 5-Lipoxygenase Enzymes, Shows Superiority to Glucosamine/ Chondroitin for Pain Management in Moderate Osteoarthritic Dogs
Osteoarthritis (OA) is a multi-factorial disease with a large metabolic component involving the accumulation of arachidonic acid… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2006
Review
2006
Villonodular synovitis in the dog: a report of four cases.
Four cases of villonodular synovitis were diagnosed by histopathology. All four dogs were treated medically with either… Expand
Is this relevant?
Review
2005
Review
2005
The role of glucosamine and chondroitin sulfate in treatment for and prevention of osteoarthritis in animals.
J disease, in particular osteoarthritis, is an important cause of lameness and debilitation for humans and other animals… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs
Objective—The purpose of this study was to determine the oral bioavailability and pharmacokinetics of a glucosamine (GL) and the… Expand
Is this relevant?
2002
2002
Development and validation of a photometric titration method for the quantitation of sodium chondroitin sulfate (bovine) in Cosequin DS chewable tablet.
A photometric titration method was developed and validated to quantitate sodium chondroitin sulfate in raw materials and Cosequin… Expand
Is this relevant?
2002
2002
Protective effect of the chondroprotective agent Cosequin DS on bovine articular cartilage exposed in vitro to nonsteroidal antiinflammatory agents.
Studies were conducted to test the hypothesis that exposure of articular cartilage to a combination of the "chondroprotective… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
2001
2001
Oral treatment with a nutraceutical (Cosequin) for ameliorating signs of navicular syndrome in horses.
Fourteen horses with a progressive forelimb lameness of 3 to 12 months' duration, diagnosed as navicular syndrome, were selected… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2001
2001
Safety of an oral chondroprotective agent in horses.
Six healthy, adult female horses were administered five times the minimum maintenance dose of an oral low-molecular-weight… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE